Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial comparing frexalimab to tacrolimus in adults undergoing kidney transplantation is currently recruiting to assess efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant Rejection

Drugs mentioned

• Frexalimab (SAR441344)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Sanofi | Conditions: Kidney Transplant Rejection | Phase 2, Phase 3 | Status: RECRUITING